4//SEC Filing
Henderson Molly 4
Accession 0001209191-23-042455
CIK 0001783183other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:00 PM ET
Size
6.1 KB
Accession
0001209191-23-042455
Insider Transaction Report
Form 4
Henderson Molly
CFO and CBO
Transactions
- Award
Common Stock
2023-07-14$1.00/sh+25,000$25,000→ 95,180 total
Holdings
- 1,134.27(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") granted on July 14, 2023. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of July 14, 2023, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]Includes 1,674 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2023.
- [F3]Includes 795.41 shares acquired under the Phathom Pharmaceuticals, Inc. 401(k) plan.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001363812
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 5:00 PM ET
- Size
- 6.1 KB